iifl-logo-icon 1
iifl-logo-icon 1
iifl-logo-icon 1
Home
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

USFDA issues Form 483 with 6 observations to Sun Pharma's Mohali facility; Stock under pressure

16 Aug 2022 , 10:44 AM

Sun Pharmaceuticals Industries Limited has updated on US FDA Inspection at Mohali Facility.
As per the filing, the US FDA has conducted an inspection of Mohali manufacturing facility (Punjab, India) of Sun Pharmaceutical Industries from August 3, 2022 to August 12, 2022. At the conclusion of the inspection, the USFDA issued a Form-483, with 6 observations. 
The Company is preparing the response to the observations, which will be submitted to USFDA within the stipulated timeline., the  company said.
It further added, "The Company is committed to address these observations promptly. The Company remains committed to work closely with the US FDA and continues to enhance its compliance on an ongoing basis."

At around 10:26 AM, Sun Pharmaceuticals Industries was currently trading at Rs910.95 per share down by Rs2.45 or 0.27% from its previous closing of Rs913.40 per share on the BSE.

Related Tags

  • Sun Pharmaceuticals Industries
  • Sun Pharmaceuticals Industries Ltd
  • Sun Pharmaceuticals Industries Ltd announcements
  • Sun Pharmaceuticals Industries Ltd launch
  • Sun Pharmaceuticals Industries Ltd news
  • Sun Pharmaceuticals Industries Ltd shares
  • Sun Pharmaceuticals Industries Ltd stocks
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Vodafone Idea FPO subscribed 18% on Day 1

Vodafone Idea FPO subscribed 18% on Day 1

Whatsapp
Facebook
Twitter
LinkedIn
18 Apr 2024|03:44 PM
Tata to Build JLR Cars in New $1 Billion Plant

Tata to Build JLR Cars in New $1 Billion Plant

Whatsapp
Facebook
Twitter
LinkedIn
18 Apr 2024|03:41 PM
Sensex, Nifty Suffer Fourth Consecutive Loss; Nifty Slips Below 22,000

Sensex, Nifty Suffer Fourth Consecutive Loss; Nifty Slips Below 22,000

Whatsapp
Facebook
Twitter
LinkedIn
18 Apr 2024|03:40 PM
950% Dividend Announced by Mahindra Group Tractor Maker

950% Dividend Announced by Mahindra Group Tractor Maker

Whatsapp
Facebook
Twitter
LinkedIn
18 Apr 2024|03:36 PM
KIMS Faces ₹306.97 Crore Income Tax Demand

KIMS Faces ₹306.97 Crore Income Tax Demand

Whatsapp
Facebook
Twitter
LinkedIn
18 Apr 2024|03:35 PM
Read More
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

closeIcon

Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp